EcoDrugPlus

Tyrosine-Protein Kinase Lyn-Like

Ensembl ID : ENSDCDG00000001389
Gene Symbol: LOC114788588
3 Cross references
196 Possible Orthologues:

Tyrosine-Protein Kinase Fyna-Like

Ensembl ID : ENSDCDG00000000554
Gene Symbol: LOC114788012
3 Cross references
192 Possible Orthologues:

Tyrosine-Protein Kinase Yes

Ensembl ID : ENSDCDG00000000947
Gene Symbol: LOC114787822
3 Cross references
197 Possible Orthologues:

Uncharacterized Loc114786463

Ensembl ID : ENSDCDG00000005635
Gene Symbol: LOC114786463
2 Cross references
193 Possible Orthologues:

Uncharacterized Loc114794133

Ensembl ID : ENSDCDG00000009896
Gene Symbol: LOC114794133
2 Cross references
194 Possible Orthologues:

Vascular Endothelial Growth Factor A

Ensembl ID : ENSDCDG00000003439
Gene Symbol: VEGFA
3 Cross references
200 Possible Orthologues:

Vascular Endothelial Growth Factor A-A-Like

Ensembl ID : ENSDCDG00000030391
Gene Symbol: LOC114791063
3 Cross references
181 Possible Orthologues:

Vitamin D Receptor

Ensembl ID : ENSDCDG00000026991
Gene Symbol: VDR
3 Cross references
394 Possible Orthologues:

Voltage-Dependent L-Type Calcium Channel Subunit Alpha-1c-Like

Ensembl ID : ENSDCDG00000035385
Gene Symbol: LOC114764596
3 Cross references
215 Possible Orthologues:

Voltage-Dependent L-Type Calcium Channel Subunit Beta-2-Like

Ensembl ID : ENSDCDG00000017316
Gene Symbol: LOC114784922
3 Cross references
204 Possible Orthologues:

Voltage-Dependent L-Type Calcium Channel Subunit Beta-4-Like

Ensembl ID : ENSDCDG00000030140
Gene Symbol: LOC114797902
3 Cross references
203 Possible Orthologues:

Voltage-Dependent N-Type Calcium Channel Subunit Alpha-1b-Like

Ensembl ID : ENSDCDG00000028234
Gene Symbol: LOC114799207
3 Cross references
214 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).